Shenzhen Weiguang Biological Products Co., Ltd. (SZSE:002880) agreed to acquire 80% stake in Ankang Huitian Plasmapheresis Station Co., Ltd. from Xia Yuzhen for CNY 22.8 million on January 6, 2023. The board of directors of Shenzhen Weiguang Biological Products approved the transaction. Ankang Huitian Plasmapheresis Station recorded total assets of 8.72 million and net liabilities of CNY 0.74 million as of August 31, 2022.